ArticlePloS one2013

Preclinical evaluation of 4-methylthiobutyl isothiocyanate on liver cancer and cancer stem cells with different p53 status.

Evelyn Lamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.